Lisbon – 16 June 2017 Biosimilar medicines: Recognising that biosimilar medicines can vastly improve access to biological medicines, the IGBA […]
Latest Data Shows the Need to Promote Biosimilar and Value Added Medicines for Better Health
Currently browsing: Oethmaan
Change is good.
Change is good. A former chairman of the Generic Medicines Trade Association, Muhammad Bodhania, is a pioneer in the pharmaceutical […]
Oethmaan Biosims – Providing Affordable and Accessible Medicines in South Africa
Summary Oethmaan Biosims is one of the newest pharmaceutical companies to emerge on the SA landscape. Content Oethmaan Biosims […]
